Current Edition

Aristea Therapeutics

How Involved Should Biopharma CEOs Be In Outsourcing Activities?

When outsourcing drug development and manufacturing, how involved should the CEOs of emerging biopharma be in the requisite day-to-day activities and processes? Louis Garguilo interviews …

Continue Reading →
biological medicines

SGS Increases Biosafety Testing Capacity at Its Glasgow Facility

SGS has just completed a significant expansion project at its Glasgow facility, meaning it can provide increased biosafety testing for the biologics, drug development, and …

Continue Reading →
drug development

Galapagos CEO to retire, though successor yet to be announced

Galapagos looked to be in a strong position at the start of 2020. It had recently closed a major research deal with Gilead that not …

Continue Reading →

Lilly’s new eczema drug scores in late-stage studies

Once known primarily for its work in diabetes, Lilly has, for years now, been branching into other areas of drug development like immunology. There, the …

Continue Reading →